Bereich
Brustzentrum St.Gallen
BZ · Dept. IV
[Hormone therapy of metastasizing breast carcinoma]
Hagen M, Thürlimann B. [Hormone therapy of metastasizing breast carcinoma]. Therapeutische Umschau. Revue thérapeutique 1996; 53:820-8.
01.11.1996[Hormone therapy of metastasizing breast carcinoma]
01.11.1996Therapeutische Umschau. Revue thérapeutique 1996; 53:820-8
Hagen M F, Thürlimann Beat
Interferon-gamma plays a key role in the human mixed lymphocyte culture.
Driessen S, aCampo C, Rink L. Interferon-gamma plays a key role in the human mixed lymphocyte culture. Bone Marrow Transplant 1996; 18:991-6.
01.11.1996Interferon-gamma plays a key role in the human mixed lymphocyte culture.
01.11.1996Bone Marrow Transplant 1996; 18:991-6
Driessen Susanne, aCampo C, Rink L
[Cytokines in mixed lymphocyte culture as a prospective parameter for transplantation].
Driessen S, Rink L. [Cytokines in mixed lymphocyte culture as a prospective parameter for transplantation]. Med Klin (Munich) 1996; 91:494-500.
15.08.1996[Cytokines in mixed lymphocyte culture as a prospective parameter for transplantation].
15.08.1996Med Klin (Munich) 1996; 91:494-500
Driessen Susanne, Rink L
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
Thürlimann B, Fey M, Senn H, Cavalli F, Jungi W, Goldhirsch A, Castiglione-Gertsch M, Bacchi M, Beretta K, Löhnert T. First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996; 7:471-9.
01.07.1996First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
01.07.1996Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996; 7:471-9
Thürlimann Beat, Fey M, Senn H J, Cavalli F, Jungi W F, Goldhirsch A, Castiglione-Gertsch M, Bacchi M, Beretta K, Löhnert T
Reverse transcription polymerase chain reaction for cytokines in the mixed lymphocyte culture. Is there a role in renal transplantation?
Driessen S, Rink L. Reverse transcription polymerase chain reaction for cytokines in the mixed lymphocyte culture. Is there a role in renal transplantation?. Nephrol Dial Transplant 1996; 11:1246-7.
01.07.1996Reverse transcription polymerase chain reaction for cytokines in the mixed lymphocyte culture. Is there a role in renal transplantation?
01.07.1996Nephrol Dial Transplant 1996; 11:1246-7
Driessen Susanne, Rink L
The changing approach to the treatment of early breast cancer
Thürlimann B, Senn H. The changing approach to the treatment of early breast cancer. The New England journal of medicine 1996; 334:1397-9.
23.05.1996The changing approach to the treatment of early breast cancer
23.05.1996The New England journal of medicine 1996; 334:1397-9
Thürlimann Beat, Senn H J
[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
Huober J, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]. Geburtshilfe und Frauenheilkunde 1996; 56:214-6.
01.04.1996[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
01.04.1996Geburtshilfe und Frauenheilkunde 1996; 56:214-6
Huober Jens, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G
Causes and treatment of bone pain of malignant origin
Thürlimann B, de Stoutz N. Causes and treatment of bone pain of malignant origin. Drugs 1996; 51:383-98.
01.03.1996Causes and treatment of bone pain of malignant origin
01.03.1996Drugs 1996; 51:383-98
Thürlimann Beat, de Stoutz N D
A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancer
Erlichman C, Fine S, Kerr I, Hoffmann W, Gorg C, Schmoll H, Preusser P, Thürlimann B, Gustavsson B. A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancer. American journal of clinical oncology 1996; 19:26-31.
01.02.1996A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancer
01.02.1996American journal of clinical oncology 1996; 19:26-31
Erlichman C, Fine S, Kerr I, Hoffmann W, Gorg C, Schmoll H J, Preusser P, Thürlimann Beat, Gustavsson B
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
Pecherstorfer M, Huss H, van Eijkeren M, Steinhauer E, Tubiana-Hulin M, Thürlimann B, Clemens M, Degardin M, Manegold C, Body J, Herrmann Z, Thiébaud D. Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76.
01.01.1996Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
01.01.1996Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76
Pecherstorfer M, Huss H J, van Eijkeren M, Steinhauer E U, Tubiana-Hulin M, Thürlimann Beat, Clemens M R, Degardin M, Manegold C, Body J J, Herrmann Z, Thiébaud D
[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]
Huober J, Sprenger H, Costa S, Zentgraf H, Schmid H, Kaufmann M, Bastert G. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]. Zentralblatt für Gynäkologie 1996; 118:560-4.
01.01.1996[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]
01.01.1996Zentralblatt für Gynäkologie 1996; 118:560-4
Huober Jens, Sprenger H, Costa S D, Zentgraf H, Schmid H, Kaufmann M, Bastert G
[Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]
Mende U, Huober J, Schmid H, Winterbauer T, Bastert G, Wannenmacher M. [Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]. Der Radiologe 1996; 36:22-30.
01.01.1996[Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography]
01.01.1996Der Radiologe 1996; 36:22-30
Mende U, Huober Jens, Schmid H, Winterbauer T, Bastert G, Wannenmacher M
Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception.
Holzer-Petsche U, Rordorf T. Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception. Br J Pharmacol 1995; 115:486-90.
01.06.1995Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception.
01.06.1995Br J Pharmacol 1995; 115:486-90
Holzer-Petsche U, Rordorf Tamara
Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.
Rordorf T, Van Horn D, Chen D, White M, Backer J. Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem 1995; 270:3662-6.
24.02.1995Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.
24.02.1995J Biol Chem 1995; 270:3662-6
Rordorf Tamara, Van Horn D J, Chen D C, White M F, Backer J M
Dexverapamil to overcome epirubicin resistance in advanced breast cancer
Thürlimann B, Hartlapp J, Gastl G, Schumacher K, Schernhammer E, Schüller J, Mross K, Greiner J, Kröger N, Kupper H. Dexverapamil to overcome epirubicin resistance in advanced breast cancer. Journal of cancer research and clinical oncology 1995; 121 Suppl 3:R3-6.
01.01.1995Dexverapamil to overcome epirubicin resistance in advanced breast cancer
01.01.1995Journal of cancer research and clinical oncology 1995; 121 Suppl 3:R3-6
Thürlimann Beat, Hartlapp J, Gastl G, Schumacher K, Schernhammer E, Schüller J, Mross K, Greiner J, Kröger N, Kupper H
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)
Joss R, Stahel R, Martinelli G, Cerny T, Thürlimann B, Leyvraz S, Bacchi M, Hürny C, Alberto P, Ludwig C. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995; 6:41-8.
01.01.1995Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)
01.01.1995Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995; 6:41-8
Joss R A, Stahel R, Martinelli G, Cerny T, Thürlimann Beat, Leyvraz S, Bacchi M, Hürny C, Alberto P, Ludwig C
Cytokines in platelet concentrates prepared from pooled buffy coats.
Klüter H, Müller-Steinhardt M, Driessen S, Wilhelm D, Kirchner H. Cytokines in platelet concentrates prepared from pooled buffy coats. Vox Sang 1995; 69:38-43.
01.01.1995Cytokines in platelet concentrates prepared from pooled buffy coats.
01.01.1995Vox Sang 1995; 69:38-43
Klüter H, Müller-Steinhardt M, Driessen Susanne, Wilhelm D, Kirchner H
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
Borner M, Cavalli F, Thürlimann B, Jungi W, Castiglione M, Harder F, Greiner R, Goldhirsch A, Bacchi M, Obrecht J. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 1994; 12:2071-7.
01.10.1994First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
01.10.1994J Clin Oncol 1994; 12:2071-7
Borner M, Cavalli F, Thürlimann Beat, Jungi W F, Castiglione M, Harder F, Greiner R, Goldhirsch A, Bacchi M, Obrecht J P
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
Sinn H, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto H. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Geburtshilfe und Frauenheilkunde 1994; 54:552-8.
01.10.1994[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]
01.10.1994Geburtshilfe und Frauenheilkunde 1994; 54:552-8
Sinn H P, Schmid H, Junkermann H, Huober Jens, Leppien G, Kaufmann M, Bastert G, Otto H F
Identification of HLA-DRB1 and HLA-DQB1 identical individuals by a cytokine-based mixed lymphocyte culture.
Driessen S, A Campo C, Kunze B, Kirchner H, Rink L. Identification of HLA-DRB1 and HLA-DQB1 identical individuals by a cytokine-based mixed lymphocyte culture. Lymphokine Cytokine Res 1994; 13:303-8.
01.10.1994Identification of HLA-DRB1 and HLA-DQB1 identical individuals by a cytokine-based mixed lymphocyte culture.
01.10.1994Lymphokine Cytokine Res 1994; 13:303-8
Driessen Susanne, A Campo C, Kunze B, Kirchner H, Rink L